REVIEW
Accepted on 28 Jul 2025
Acoustic Therapy for Allergic Rhinitis and Chronic Rhinosinusitis: Modulating Microbiome, Immunity and Well-Being
doi 10.3389/falgy.2025.1649031
- 246 views
- Frontiers in Allergy
- Rhinology
- Research Topics
- Recent Advances in Rhinology 2024
Recent Advances in Rhinology 2024
3,057
Total downloads
14k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
ORIGINAL RESEARCH
Published on 30 Jun 2025
ULANC - EUFOREA workshop 2024: bringing the concept of global airways to the frontline of medical care
doi 10.3389/falgy.2025.1581694
- 974 views
ORIGINAL RESEARCH
Published on 05 Jun 2025
Epigenetic modifications are associated with mRNA and cytokine expression changes in chronic rhinosinusitis: a multiomics study from the United States
doi 10.3389/falgy.2025.1606255
- 1,354 views
ORIGINAL RESEARCH
Published on 24 Feb 2025
Raising the bar in respiratory care by EUFOREA: report of the European Union Parliament Symposium, April 2024
doi 10.3389/falgy.2025.1540499
- 1,561 views
ORIGINAL RESEARCH
Published on 03 Feb 2025
EUFOREA meeting on defining disease states in allergic rhinitis: towards a unified language in AR
doi 10.3389/falgy.2024.1531788
- 2,758 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
European biologic training course for type 2 inflammation by EUFOREA in 2024: key facts and lessons learned
doi 10.3389/falgy.2024.1517122
- 1,491 views
CASE REPORT
Published on 01 Nov 2024
Case Report: Dual monoclonal antibody therapy in chronic rhinosinusitis with nasal polyps and severe eosinophilic asthma—a proteome analysis
doi 10.3389/falgy.2024.1484931
- 1,648 views
BRIEF RESEARCH REPORT
Published on 28 Aug 2024
Innovations in the management of epistaxis secondary to hereditary hemorrhagic telangiectasia: our evolution to injection sclerotherapy as the treatment of choice
doi 10.3389/falgy.2024.1456686
- 910 views
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.